Gregory L. Shiferman - 01 Apr 2026 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Reporting relationship: SVP and General Counsel
Issuer ticker: VYGR
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 17:42:56 UTC
Prior SEC filing: 08 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory L. Shiferman

Key filing fact

Gregory L. Shiferman filed Form 4 for Voyager Therapeutics, Inc. (VYGR) on 03 Apr 2026.

Key facts

This page summarizes Gregory L. Shiferman's Form 4 filing for Voyager Therapeutics, Inc. (VYGR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 17:42.

Change

Previous filing in this sequence was filed on 08 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002041689 Primary reporting owner

Shiferman Gregory L.

Relationship: SVP and General Counsel
Address: C/O VOYAGER THERAPEUTICS, INC., 75 HAYDEN AVENUE, LEXINGTON
Signature: /s/ Gregory L. Shiferman
Signature date: 03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VYGR transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %
Price: $0.000000^*
Shares after: 50,000
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of shares of common stock issuable under an aggregate of 50,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, April 1, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.